Related Experiment Video
Updated: Apr 30, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Hypertension and obesity after pediatric kidney transplantation: management based on pathophysiology: a mini review
Eunice G John1, Liezl T Domingo2
1Department of Pediatrics, Division of Pediatric Nephrology, University of Illinois at Chicago, Chicago, Illinois, USA.
Insights
Hypertension is a common risk after pediatric kidney transplants, impacting survival. Managing blood pressure and obesity requires considering immunosuppression and comorbidities to protect the graft.
Area of Science:
- Nephrology
- Pediatric Transplant Medicine
- Cardiovascular Research
Background:
- Hypertension is a frequent complication post-pediatric renal transplant, significantly affecting graft survival and patient outcomes.
- The mechanisms underlying post-kidney transplant hypertension are intricate and influenced by multiple factors.
- Effective blood pressure management in these patients is crucial yet challenging, with many cases remaining uncontrolled.
Purpose of the Study:
- To explore the complex pathophysiology of hypertension and obesity in pediatric kidney transplant recipients.
- To identify key factors influencing blood pressure control in this unique population.
- To inform management strategies balancing immunosuppression needs with cardiovascular health.
Main Methods:
- Review of existing literature on pediatric renal transplant hypertension and obesity.
- Analysis of factors including immunosuppressive drug side effects, disease recurrence, and comorbidities.
- Consideration of the interplay between obesity, hypertension, and graft survival.
Main Results:
- Post-transplant hypertension is multifactorial, complicated by immunosuppression, recurrent disease, and obesity.
- Standard pediatric hypertension guidelines may need adaptation for transplant patients.
- Achieving optimal blood pressure control is often hindered by these complex interactions.
Conclusions:
- Management of hypertension and obesity in pediatric kidney transplant recipients demands a pathophysiology-based approach.
- Special attention must be given to immunosuppressive side effects and comorbidities like obesity.
- Further prospective studies are needed to optimize management strategies and improve long-term outcomes.
Abstract:
Hypertension after pediatric renal transplant is a common and important risk factor for graft loss and patient survival. The mechanism of post kidney transplant hypertension is complex and multifactorial. Control of blood pressure in renal transplant patients is important but often times blood pressures remain uncontrolled. The management of hypertension and obesity in pediatric kidney transplant patients is based on the pathophysiology. Compared to the general pediatric hypertensive population, special attention needs to be focused on the additional impact of immunosuppressive medications side effects and interactions, recurrent disease, and donor and recipient comorbidities such as obesity on blood pressure control with thoughtful consideration of the risk of graft failure. In general, there is a need for prospective studies in pediatric kidney transplant patients to understand the pathophysiology of hypertension and obesity and the appropriate approach to achieve a balance between the primary need to avoid rejection and the need to lower blood pressure and prevent obesity.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease III: Interprofessional Care
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure

